NYSE:RCUSBiotechs
A Look At Arcus Biosciences (RCUS) Valuation After Recent Share Price Weakness
Why Arcus Biosciences (RCUS) is on investors’ radar
Arcus Biosciences (RCUS) has drawn fresh attention after recent trading left the shares around $19.96, with returns showing mixed signals across the past week, month, past 3 months, and year to date.
For investors tracking longer term performance, Arcus shows a 1 year total return of 57.17%, alongside a 3 year total return near 3% and a 5 year total return that reflects meaningful volatility over time.
See our latest analysis for Arcus...